Fibroblast Growth Factor Receptor (FGFR) Inhibitors for the Treatment of Cholangiocarcinoma: Key Therapeutic Developments and Knowledge Gaps. [PDF]
Erul E +7 more
europepmc +1 more source
Design, synthesis and biological evaluation of inhibitors of FGFR, VEGFR-2 and Ras proteins
Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiological functions such as growth and survival.
Jayakanth, Kankanala
core
Targeted therapies for urothelial carcinoma: From FGFR inhibitors to next‑generation antibody-drug conjugates (Review). [PDF]
Du J, Shen H, Zeng T, Liu W, Xie Y.
europepmc +1 more source
Design, Synthesis, and Biological Evaluation of 5',7-Disubstituted 7-Deaza-adenosine Analogues as Irreversible Pan-FGFR Inhibitors. [PDF]
Park JH +15 more
europepmc +1 more source
Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors. [PDF]
Kostopoulou ON +7 more
europepmc +1 more source
FGFR Inhibitors in Urothelial Cancer: From Scientific Rationale to Clinical Development. [PDF]
Kwon WA.
europepmc +1 more source
Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations. [PDF]
Holzhauser S +7 more
europepmc +1 more source
Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures. [PDF]
Kähkönen TE +12 more
europepmc +1 more source
Design, Synthesis, and Biological Evaluation of 3-Amino-pyrazine-2-carboxamide Derivatives as Novel FGFR Inhibitors. [PDF]
Zheng J +9 more
europepmc +1 more source

